loading page

Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.
  • +1
  • Almurtada Razok,
  • Abdullah Shams,
  • Ahmed Almeer,
  • Muhammad Zahid
Almurtada Razok
Hamad Medical Corporation
Author Profile
Abdullah Shams
Hamad Medical Corporation
Author Profile
Ahmed Almeer
Hamad Medical Corporation
Author Profile
Muhammad Zahid
Hamad Medical Corporation
Author Profile

Abstract

Guillain-Barré syndrome is an immune-mediated neuropathy that was reported following multiple vaccines. We present the case of a gentleman who developed GBS 20 days after the second dose of COVID-19 vaccination. It is important to mention that more research is needed to establish an association between COVID-19 vaccine and GBS.